Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation

Inflammatory Bowel Diseases

Volumn 17, Issue 1, 2011, Pages 221-231

  Olaru, Alexandru V ^a   Selaru, Florin M ^a   Mori, Yuriko ^a   Vazquez, Christine ^a   David, Stefan ^a   Paun, Bogdan ^a   Cheng, Yulan ^a   Jin, Zhe ^a   Yang, Jian ^a   Agarwal, Rachana ^a   Abraham, John M ^a   Dassopoulos, Themistocles ^b   Harris, Mary ^c   Bayless, Theodore M ^a   Kwon, John ^a   Harpaz, Noam ^d   Livak, Ferenc ^e   Meltzer, Stephen J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c Mercy Hospital   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

factor inhibiting hypoxia inducible factor 1; IBD related neoplasia; inflammatory bowel disease; microRNA

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; LUCIFERASE; MICRORNA; MICRORNA 31; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMPUTER MODEL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENTERITIS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROCTOCOLECTOMY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATORY BOWEL DISEASES; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 78650108135     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21359     Document Type: Article

References (29)

1. Eaden JA, Abrams KR, Mayberry JF,. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001; 48: 526-535.
2. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005; 100: 2724-2729.
3. Eaden J, Abrams K, McKay H, et al. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol. 2001; 194: 152-157.
4. Itzkowitz SH, Harpaz N,. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2004; 126: 1634-1648.
5. Bartel DP,. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136: 215-233.
6. Croce CM,. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10: 704-714.
7. He L, Thomson JM, Hemann MT, et al. microRNA polycistron as a potential human oncogene. Nature. 2005; 435: 828-833.
8. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A. 2006; 103: 7024-7029.
9. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002; 99: 15524-15529.
10. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102: 13944-13949.
11. Kan T, Sato F, Ito T, et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology. 2009; 136: 1689-1700.
12. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008; 13: 272-286.
13. Wu F, Zikusoka M, Trindade A, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology. 2008; 135: 1624-1635 e24.
14. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut. 2005; 54: 374-384.
15. Itzkowitz S,. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol. 2003; 36: S70-74; discussion S94-96.
16. Risques RA, Rabinovitch PS, Brentnall TA,. Cancer surveillance in inflammatory bowel disease: new molecular approaches. Curr Opin Gastroenterol. 2006; 22: 382-390.
17. Selaru FM, Xu Y, Yin J, et al. Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology. 2002; 122: 606-613.
18. Bandres E, Cubedo E, Agirre X, et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006; 5: 29.
19. Slaby O, Svoboda M, Fabian P, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology. 2007; 72: 397-402.
20. Sarver AL, French AJ, Borralho PM, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 2009; 9: 401.
21. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105: 10513-10518.
22. Carmeliet P, Jain RK,. Angiogenesis in cancer and other diseases. Nature. 2000; 407: 249-257.
23. Scaldaferri F, Vetrano S, Sans M, et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology. 2009; 136: 585-595 e5.
24. Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology. 2006; 130: 2060-2073. (Pubitemid 43816964)
25. Fishman SJ, Feins NR, D'Amato RJ, et al. Long-term remission of Crohn's disease treated with thalidomide: a seminal case report. Angiogenesis. 1999; 3: 201-204.
26. Calvani M, Rapisarda A, Uranchimeg B, et al. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood. 2006; 107: 2705-2712.
27. Eatock MM, Schatzlein A, Kaye SB,. Tumour vasculature as a target for anticancer therapy. Cancer Treat Rev. 2000; 26: 191-204.
28. Rademakers SE, Span PN, Kaanders JH, et al. Molecular aspects of tumour hypoxia. Mol Oncol. 2008; 2: 41-53.
29. Liu CJ, Tsai MM, Hung PS, et al. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res. 2010 70 (4): 1635-44.